6n54: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
m Protected "6n54" [edit=sysop:move=sysop]
OCA (talk | contribs)
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Unreleased structure'''


The entry 6n54 is ON HOLD
==Crystal structure of human uridine-cytidine kinase 2 complexed with 2'-azidocytidine monophosphate==
<StructureSection load='6n54' size='340' side='right'caption='[[6n54]], [[Resolution|resolution]] 2.42&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[6n54]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6N54 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6N54 FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.424&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=KEA:2-azido-2-deoxycytidine+5-(dihydrogen+phosphate)'>KEA</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6n54 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6n54 OCA], [https://pdbe.org/6n54 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6n54 RCSB], [https://www.ebi.ac.uk/pdbsum/6n54 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6n54 ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/UCK2_HUMAN UCK2_HUMAN] Phosphorylates uridine and cytidine to uridine monophosphate and cytidine monophosphate. Does not phosphorylate deoxyribonucleosides or purine ribonucleosides. Can use ATP or GTP as a phosphate donor. Can also phosphorylate cytidine and uridine nucleoside analogs such as 6-azauridine, 5-fluorouridine, 4-thiouridine, 5-bromouridine, N(4)-acetylcytidine, N(4)-benzoylcytidine, 5-fluorocytidine, 2-thiocytidine, 5-methylcytidine, and N(4)-anisoylcytidine.
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Tissues and organs are composed of diverse cell types, which poses a major challenge for cell-type-specific profiling of gene expression. Current metabolic labeling methods rely on exogenous pyrimidine analogs that are only incorporated into RNA in cells expressing an exogenous enzyme. This approach assumes that off-target cells cannot incorporate these analogs. We disprove this assumption and identify and characterize the enzymatic pathways responsible for high background incorporation. We demonstrate that mammalian cells can incorporate uracil analogs and characterize the enzymatic pathways responsible for high background incorporation. To overcome these limitations, we developed a new small molecule-enzyme pair consisting of uridine/cytidine kinase 2 and 2'-azidouridine. We demonstrate that 2'-azidouridine is only incorporated in cells expressing uridine/cytidine kinase 2 and characterize selectivity mechanisms using molecular dynamics and X-ray crystallography. Furthermore, this pair can be used to purify and track RNA from specific cellular populations, making it ideal for high-resolution cell-specific RNA labeling. Overall, these results reveal new aspects of mammalian salvage pathways and serve as a new benchmark for designing, characterizing and evaluating methodologies for cell-specific labeling of biomolecules.


Authors: Cuthbert, B.J., Nainar, S., Spitale, R.C., Goulding, C.W.
An optimized chemical-genetic method for cell-specific metabolic labeling of RNA.,Nainar S, Cuthbert BJ, Lim NM, England WE, Ke K, Sophal K, Quechol R, Mobley DL, Goulding CW, Spitale RC Nat Methods. 2020 Feb 3. pii: 10.1038/s41592-019-0726-y. doi:, 10.1038/s41592-019-0726-y. PMID:32015544<ref>PMID:32015544</ref>


Description: Crystal structure of human uridine-cytidine kinase 2 complexed with 2'-azidocytidine monophosphate
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
[[Category: Unreleased Structures]]
</div>
[[Category: Cuthbert, B.J]]
<div class="pdbe-citations 6n54" style="background-color:#fffaf0;"></div>
[[Category: Nainar, S]]
== References ==
[[Category: Goulding, C.W]]
<references/>
[[Category: Spitale, R.C]]
__TOC__
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Cuthbert BJ]]
[[Category: Goulding CW]]
[[Category: Nainar S]]
[[Category: Spitale RC]]

Latest revision as of 06:45, 11 October 2023

Crystal structure of human uridine-cytidine kinase 2 complexed with 2'-azidocytidine monophosphate

6n54, resolution 2.42Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA